Comparative Analysis of Retinal Organotypic Cultures and In Vivo Axotomized Retinas

Author:

González-Riquelme María José1,Lucas-Ruiz Fernando1ORCID,Galindo-Romero Caridad1ORCID,Boia Raquel2345ORCID,Ambrósio António Francisco2345ORCID,Vidal-Sanz Manuel1ORCID,Raquel Santiago Ana23456ORCID,Agudo-Barriuso Marta1ORCID

Affiliation:

1. Experimental Ophthalmology Group, Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca (IMIB-Arrixaca) & Universidad de Murcia, 30120 Murcia, Spain

2. University of Coimbra, Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, 3000-548 Coimbra, Portugal

3. University of Coimbra, Centre for Innovative Biomedicine and Biotechnology (CIBB), 3000-075 Coimbra, Portugal

4. Clinical Academic Centre of Coimbra (CACC), 3000-075 Coimbra, Portugal

5. Association for Innovation and Biomedical Research on Light and Image, 3000-548 Coimbra, Portugal

6. University of Coimbra, Institute of Immunology, Faculty of Medicine, 3000-548 Coimbra, Portugal

Abstract

Retinal organotypic cultures (ROCs) are used as an in vivo surrogate to study retinal ganglion cell (RGC) loss and neuroprotection. In vivo, the gold standard to study RGC degeneration and neuroprotection is optic nerve lesion. We propose here to compare the course of RGC death and glial activation between both models. The left optic nerve of C57BL/6 male mice was crushed, and retinas analyzed from 1 to 9 days after the injury. ROCs were analyzed at the same time points. As a control, intact retinas were used. Retinas were studied anatomically to assess RGC survival, microglial, and macroglial activation. Macroglial and microglial cells showed different morphological activation between models and were activated earlier in ROCs. Furthermore, microglial cell density in the ganglion cell layer was always lower in ROCs than in vivo. RGC loss after axotomy and in vitro followed the same trend up to 5 days. Thereafter, there was an abrupt decrease in viable RGCs in ROCs. However, RGC somas were still immuno-identified by several molecular markers. ROCs are useful for proof-of-concept studies on neuroprotection, but long-term experiments should be carried out in vivo. Importantly, the differential glial activation observed between models and the concomitant death of photoreceptors that occurs in vitro may alter the efficacy of RGC neuroprotective therapies when tested in in vivo models of optic nerve injury.

Funder

Spanish Ministry of Economy and Competitiveness

Instituto de Salud Carlos III

Fondo Europeo de Desarrollo Regional

Fundación Séneca

Agencia de Ciencia y Tecnología Región de Murcia

FCT-Portugal

Centro2020 Regional Operational Programme

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3